188 related articles for article (PubMed ID: 9539656)
21. [Lysozyme in children with acute and chronic inflammatory intestinal diseases].
Dick W; Braun OH; Nagel W
Padiatr Padol; 1985; 20(2):143-50. PubMed ID: 3991222
[TBL] [Abstract][Full Text] [Related]
22. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
24. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
Mirsepasi-Lauridsen HC; Bachmann Holmetoft U; Ingdam Halkjær S; Angeliki Krogfelt K; Munk Petersen A
Scand J Gastroenterol; 2016; 51(2):211-7. PubMed ID: 26359672
[TBL] [Abstract][Full Text] [Related]
25. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637
[TBL] [Abstract][Full Text] [Related]
26. Validation of the spanish version of the inflammatory bowel disease questionnaire on ulcerative colitis and Crohn's disease.
López-Vivancos J; Casellas F; Badia X; Vilaseca J; Malagelada JR
Digestion; 1999; 60(3):274-80. PubMed ID: 10343142
[TBL] [Abstract][Full Text] [Related]
27. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
Vucelić B; Krznarić Z; Sentić M; Milicić D; Korać B; Cvorisćec D; Stavljenić A
Lijec Vjesn; 1990; 112(9-10):281-4. PubMed ID: 2093781
[TBL] [Abstract][Full Text] [Related]
28. Lysozyme gene expression in inflammatory bowel disease.
Stamp GW; Poulsom R; Chung LP; Keshav S; Jeffery RE; Longcroft JA; Pignatelli M; Wright NA
Gastroenterology; 1992 Aug; 103(2):532-8. PubMed ID: 1634071
[TBL] [Abstract][Full Text] [Related]
29. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
[TBL] [Abstract][Full Text] [Related]
30. Comparison of RANTES expression in Crohn's disease and ulcerative colitis: an aid in the differential diagnosis?
Ansari N; Abdulla J; Zayyani N; Brahmi U; Taha S; Satir AA
J Clin Pathol; 2006 Oct; 59(10):1066-72. PubMed ID: 16565224
[TBL] [Abstract][Full Text] [Related]
31. Ultrasound findings in Crohn's disease and ulcerative colitis: a prospective study.
Worlicek H; Lutz H; Heyder N; Matek W
J Clin Ultrasound; 1987; 15(3):153-63. PubMed ID: 3134409
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease.
Klockars M; Reitamo S; Reitamo JJ; Möller C
Gut; 1977 May; 18(5):377-81. PubMed ID: 326636
[TBL] [Abstract][Full Text] [Related]
33. Fecal proteolytic profiling of pediatric inflammatory bowel disease: A pilot study.
Haak W; Jagt JZ; de Meij TGJ; Bikker FJ; Brand HS; de Boer NKH; Kaman WE
FASEB J; 2024 May; 38(9):e23627. PubMed ID: 38690708
[TBL] [Abstract][Full Text] [Related]
34. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
[TBL] [Abstract][Full Text] [Related]
35. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
Palone F; Vitali R; Cucchiara S; Mennini M; Armuzzi A; Pugliese D; DʼIncà R; Barberio B; Stronati L
Inflamm Bowel Dis; 2016 Dec; 22(12):2886-2893. PubMed ID: 27755215
[TBL] [Abstract][Full Text] [Related]
36. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
[TBL] [Abstract][Full Text] [Related]
37. Fecal radioiodide excretion following intravenous injection of 131-I-albumin and 125-I-immunoglobulin G in chronic inflammatory bowel disease. An aid to topographic diagnosis.
Jarnum S; Jensen KB
Gastroenterology; 1975 Jun; 68(6):1433-44. PubMed ID: 1132626
[TBL] [Abstract][Full Text] [Related]
38. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
[TBL] [Abstract][Full Text] [Related]
39. Serum lysozyme, serum proteins, and immunoglobulin determinations in nonspecific inflammatory bowel disease.
El-Khatib OS; Lebwohl O; Attia AA; Flood CA; Stein JA; Sweeting JG; Whitlock RT; Osserman EF; Holt PR
Am J Dig Dis; 1978 Apr; 23(4):297-301. PubMed ID: 665622
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis.
Fahlgren A; Hammarström S; Danielsson A; Hammarström ML
Clin Exp Immunol; 2003 Jan; 131(1):90-101. PubMed ID: 12519391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
